Mayo Clinic Talks

Host: Darryl S. Chutka, M.D., [@chutkaMD] Guest: Timothy I. Morgenthaler, M.D. It’s estimated that about 30 million people in the U.S. have sleep apnea and most don’t even know they have it. Only 20% of those with sleep apnea have been diagnosed with the condition. Sleep apnea becomes more common with advancing age and is thought to be present in up to 80% of men over the age of 80. With an increased prevalence of obesity in our population, the numbers of those with sleep apnea has increased dramatically. We’re all aware of the daytime drowsiness that is so common in patients who are untreated, but there are other numerous and potentially serious complications that can also occur. In today’s podcast, we’ll discuss the common presenting symptoms of sleep apnea, how to diagnose the condition, and the potential consequences in those who remain untreated. Our guest is Timothy I. Morgenthaler, M.D., a sleep specialist from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D., [@chutkaMD] Guest: Bradley C. Liebovich, M.D. Testicular cancer accounts for only around 1% of all cancers in men and is most common in males from age 15 to 35. Around 10,000 new cases are diagnosed per year resulting in about 400 deaths. While testicular cancer is relatively uncommon, other abnormalities occur in the scrotum which are quite common and fortunately, relatively benign. Most of these conditions present as a scrotal mass and can be quite frightening to the patient if they discover them.  In today’s podcast, we’ll discuss scrotal masses including testicular cancer with our guest, Bradley C. Liebovich, M.D., from the Department of Urology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Eric J. Olson, M.D. It’s estimated that about 30 million people in the U.S. have sleep apnea and the worldwide prevalence is approaching 1 billion. The traditional treatment is continuous positive airway pressure or CPAP which is quite effective and used to enhance ventilation. Unfortunately, there are a significant number of patients with sleep apnea who can’t tolerate CPAP. This may result in an untreated patient, increasing their risks to a variety of potentially serious complications. How do we manage the CPAP-intolerant patient? What else is available for the patient with sleep apnea? Which patients are candidates for these alternative treatments and how effective are they? In this podcast, we’ll discuss these questions and more with our guest, sleep expert Eric J. Olson, M.D., from the Division of Pulmonary and Critical Care at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Michael H. Silber, M.B., Ch.B. Depending on the patient, a complaint of feeling tired, fatigued or sleepy may all mean the same thing. In others they may not feel that sleepiness is the same as fatigue or tiredness. Once we sort out what the patient is actually describing, how do we evaluate the sleepy patient? How much sleep do we need per night and what’s an inadequate amount of sleep? How do we evaluate the quality of a patient’s sleep and what role does age play in the evaluation of a patient’s sleep? These are questions we’ll discuss with our guest for this podcast, Michael H. Silber, M.B., Ch.B., a neurologist and sleep expert at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Michael D. Leise, M.D. The liver is the second-most transplanted organ; nearly 10,000 patients received a liver transplant in 2021. The major factor, which has limited the transplants performed, has been the availability of the donated organs and some patients have waited several years before an acceptable organ becomes available. Transplants can be performed for a variety of end-stage liver diseases, usually giving patients years of additional life. Who’s a candidate for a liver transplant and what criteria for selection are required? Our topic for this podcast is “Liver Transplant Selection Criteria” and we’ll discuss this topic with our guest, Michael D. Leise, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Dr. Samy M. Riad, an expert in kidney transplants and post-transplant care, discusses the unique medical needs of transplant patients, the transition of care for kidney transplant recipients, the importance of immunizations, managing cardiovascular risk factors, and key points about post-transplant care for kidney transplant patients.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Scott M. Cheney, M.D. Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D., a urologist from the Mayo Clinic in Phoenix, Arizona. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Alan H. Bryce, M.D. Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early, and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D., from the Division of Hematology and Oncology at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Nahid Punjani, M.D., M.P.H. Issues related to the prostate can play a significant role in a man’s sexual function. We commonly use medications for benign prostate problems such as BPH which can produce adverse effects. It’s also very common for the treatment of prostate cancer, whether we use radiation therapy, surgical prostatectomy, or hormonal therapy to cause sexual dysfunction. In this podcast, we’ll review the important role the prostate plays in sexual function as we discuss the “Prostate and Sexual Health” with our guest, Nahid Punjani, M.D., M.P.H., a urologist at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: R. Jeffrey Karnes, M.D. Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime.  When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each?  Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.